Glyphic Biotechnologies

Glyphic Biotechnologies is a biotechnology startup based in New York, New York. The company employs 29 people. Glyphic Biotechnologies specializes in protein sequencing, aiming to advance the understanding of biology and disease. They are developing a next-generation protein sequencing platform to provide researchers with deeper biological insights. The company believes proteins offer a more comprehensive understanding of biological processes compared to DNA analysis, as proteins directly reflect the actions within our bodies. Their platform is designed to unlock novel discoveries in proteomics, a field crucial for understanding complex biological systems. For more information about Glyphic Biotechnologies and their revolutionary protein sequencing platform, visit their website at glyphic.bio.